$RYAN

RYAN SPECIALTY REPORTS THIRD QUARTER 2026 RESULTS

RYAN SPECIALTY HOLDINGS, INC. (RYAN) filed an SEC Form 8-K — Results of Operations and Financial Condition. 1 RYAN SPECIALTY REPORTS THIRD QUARTER 2026 RESULTS - Total Revenue grew 4.7% year-over-year to $790.0 million - - Organic Revenue Growth Rate* of 4.0% year-over-year - - Net Income of $88.0 million , or $0.29 per diluted share - - Adjusted EBITDAC* grew 3.8% year-over-year to $2

Original reporting
Published Oct 29, 2026, 8:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 8:14 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$RYAN
Bullish
high confidence
Mentioned
$RYAN
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$RYANBullishHigh
01

Why it matters

The earnings beat and capital return signal financial health, likely supporting a short‑term price rally.

02

Market read

First‑hand earnings data provides fresh trading impetus for RYAN and peers in the specialty insurance space.

03

What to watch

Higher compensation costs and restructuring expenses may pressure future earnings.

Relevance 7/10Novelty 8/10Timing: after-hours

Background

Ryan Specialty Holdings reported its third‑quarter 2026 financial results via an SEC Form 8‑K.

Company-level read

Ticker impact

$RYANBullishHigh confidence
Context

RYAN disclosed Q3 2026 earnings with revenue up 4.7% YoY to $790M and net income up 40.6% to $88M.

Expected impact

likely upward pressure as market prices in stronger-than-expected earnings.

Evidence & confidence

Revenue and net income both rose year‑over‑year, and the company returned capital, indicating financial strength.

Market effects

Specialty insurance sector may see modest uplift from Ryan's earnings beat.

U.S. market participants may react positively to the results.

Limited to insurance and financial services investors.

Counterpoint

Growth rates are slowing; margin compression could limit upside.

Key entities

  • Patrick G. Ryan

    Founder and Executive Chairman who commented on the results.

  • Timothy W. Turner

    CEO who highlighted operational performance.

Related articles

$RYANMedAI 8/10

Ryan Specialty: Q3 Earnings Snapshot

Ryan Specialty Group Holdings Inc. (RYAN) reported Q3 net income of $88 million, or 29 cents per share, with adjusted earnings of 51 cents per share, exceeding analyst expectations of 49 cents. Revenue was $790 million, surpassing the forecasted $788.8 million.

High

Revenue rose 4.7%, but Ryan Specialty's organic growth slowed to 4% from 15%

Ryan Specialty reported Q3 2026 revenue growth of 4.7% YoY to $789.96M, with organic growth slowing to 4% from 15%. Net income rose 40.6% to $88.05M, while adjusted EBITDAC increased 3.8% to $244.45M. The company returned $173.7M to shareholders through stock repurchases and dividends. Management cited challenging market conditions but expressed confidence in long-term value creation. (Character count: 349)

$RYANMedAI 8/10

Ryan Specialty posts Q2 revenue gain as E&S market slows

Ryan Specialty Holdings, Inc. reported second-quarter 2026 net commissions and fees of $902.7 million, up 7.4% year-over-year. Total revenue for the quarter reached $916.6 million, a 7.2% increase from $855.2 million a year earlier. Organic revenue growth came in at 6.7%, down from 7.1% in the prior-year period. The deceleration continues a trend across multiple quarters as the broader E&S market moderates.